bpc 157 hims & Hers shares are trading higher after an FDA advisory panel recommended adding BPC-157 to the 503A compounding list, potentially widening access through licensed pharmacies HIMS jumps more than 7%
HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer HIMS THE VOTE FOR BPC 157 HAPPENS AT 11:45 A.M. ET BPC 157 PURE Immediate Release Heart + Sol BPC 157 Wholesale Pricing
Pay in 4 interest-free payments of $7.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



